Unknown

Dataset Information

0

Recombinant growth hormone therapy in a girl with Costello syndrome: a 4-year observation.


ABSTRACT: Costello syndrome is a rare syndrome of multiple congenital anomalies. The typical clinical traits include dysmorphic craniofacial features, skin hyperpigmentation and excess, feeding difficulties leading to severe postnatal growth retardation, short stature, joint hypermobility, and delayed psychomotor development. Additionally, Costello syndrome may present with an increased incidence of congenital heart disease, hypertrophic cardiomyopathy, and increased risk of both benign and malignant tumors. Furthermore, cases of patients with endocrine disorders such as adrenal insufficiency and endogenous growth hormone deficiency have also been documented.We present a patient with Costello syndrome who has been successfully treated with recombinant human growth hormone (rhGH) for almost 4 years.The possibility of growth hormone (GH) treatment can be considered in cases of documented GH deficiency in patients with Costello syndrome, but only under close oncologic and cardiologic supervision.

SUBMITTER: Blachowska E 

PROVIDER: S-EPMC4729164 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recombinant growth hormone therapy in a girl with Costello syndrome: a 4-year observation.

Blachowska Ewa E   Petriczko Elżbieta E   Horodnicka-Józwa Anita A   Skórka Agata A   Pelc Magdalena M   Krajewska-Walasek Małgorzata M   Walczak Mieczysław M  

Italian journal of pediatrics 20160126


<h4>Background</h4>Costello syndrome is a rare syndrome of multiple congenital anomalies. The typical clinical traits include dysmorphic craniofacial features, skin hyperpigmentation and excess, feeding difficulties leading to severe postnatal growth retardation, short stature, joint hypermobility, and delayed psychomotor development. Additionally, Costello syndrome may present with an increased incidence of congenital heart disease, hypertrophic cardiomyopathy, and increased risk of both benign  ...[more]

Similar Datasets

| S-EPMC9625759 | biostudies-literature
| S-EPMC7336260 | biostudies-literature
| S-EPMC9221830 | biostudies-literature
| S-EPMC7534522 | biostudies-literature
| S-EPMC4485705 | biostudies-other
| S-EPMC8662840 | biostudies-literature
| S-EPMC3789886 | biostudies-literature
| S-EPMC6312920 | biostudies-literature
| S-EPMC5785645 | biostudies-literature
| S-EPMC6517261 | biostudies-literature